MAPK1 and pancreatic neoplasm: Future targeted strategies in this unique subgroup of pancreatic tumors should consider strategies like dual blockade of the MAPK pathway or combination therapies like MEK or ERK inhibition in combination with autophagy inhibition shown in preclinical testing to act synergistically [16].